Biomedica Polyclonal Anti-human C4d antibody

Monday, 17 September, 2012 | Supplied by: United Bioresearch Products Pty Ltd

The Polyclonal Anti-human C4d antibody from Biomedica has been designed to identify human complement split product C4d. It is suggested to be a valuable marker for humoral rejection of kidney transplantations.

Supplied at a concentration of 0.2 mg/mL in 250 µL liquid IgG purified by protein G chromatography, the antibody has been tested for use on paraffin sections and frozen sections of human tissue.

Online: www.unitedbioresearch.com.au
Phone: 02 4575 0309

Antibodies Inc recombinant antibodies

Recombinant chimeric antibodies are designed to offer several advantages beyond easy multiplexing.

Bioss Multiplex Fluorescent IHC Staining Kit

The Bioss Multiplex Fluorescent (5 Colors) IHC Staining Kit enables the simultaneous detection of...

AdipoGen immune checkpoint reagents for immuno-oncology research

AdipoGen Life Sciences offers a broad panel of immune checkpoint reagents, including recombinant...

Content from other channels on our network

Government invests $1.5m in regional science partnerships

Desalination marine works conclude at Belmont

Zip Water releases 2025 Sustainability Report

Australia's EV fleet transition will be won or lost at the depot

Smart stormwater system removes harmful pollutants

A new national approach to clinical governance

Opinion: The debate over the government's aged care algorithm is missing the point

Commonwealth Home Support Program extended to 30 June 2029

When Connectivity Becomes Critical Care — Webinar

Unregistered doctor convicted after patient is hospitalised following medical procedure

eBeam technology evaluated for poultry food safety and flavour

When production outgrows storage: the food and beverage warehouse challenge

Integrated bulk handling system boosts gluten-free food production

Snack brand Nibblish focused on sustainable business model

Making cultivated meat more viable by re-using waste